← Back to Clinical Trials
Recruiting NCT05917626

NCT05917626 Effectiveness and Implementation of a Digital Intervention for Pediatric Chronic Pain Co-designed With Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05917626
Status Recruiting
Phase —
Sponsor University of Malaga
Condition Chronic Pain
Study Type INTERVENTIONAL
Enrollment 195 participants
Start Date 2023-05-05
Primary Completion 2027-10

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Digital SPA

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 195 participants in total. It began in 2023-05-05 with a primary completion date of 2027-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Children and adolescents with chronic pain often lack a proper diagnosis and treatment. Research has shown that, if left untreated, it usually doesn't resolve and continues through adulthood. The goal of this multi-phase study is to co-develop (with patients), test, and implement a smartphone app called "Digital Solution for Pain in Adolescents" (Digital SPA) which can provide pain management resources to children with chronic pain and their parents, preventing future disability. Participants will: participate in individual and group interviews, respond to questionnaires online and try a smartphone app.

Eligibility Criteria

Inclusion Criteria: * Adolescents age 12-17 years * Has had non-oncologic chronic pain for at least 3 months (e.g., abdominal pain, headache or musculoskeletal pain) * Has Internet access * One parent is willing to participate (and both give consent for their child to participate) Exclusion Criteria: * Diagnosis of a comorbid serious health condition (e.g., cancer) * Parent or child does not speak or read Spanish * Active psychosis or suicidal ideation

Contact & Investigator

Central Contact

Rocio de la Vega, PhD

✉ rocio.delavega@uma.es

📞 +34634014362

Principal Investigator

Rocio de la Vega, PhD

PRINCIPAL INVESTIGATOR

University of Malaga

Frequently Asked Questions

Who can join the NCT05917626 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05917626 currently recruiting?

Yes, NCT05917626 is actively recruiting participants. Contact the research team at rocio.delavega@uma.es for enrollment information.

Where is the NCT05917626 trial being conducted?

This trial is being conducted at Almería, Spain, Barcelona, Spain, Granada, Spain, Madrid, Spain and 2 additional locations.

Who is sponsoring the NCT05917626 clinical trial?

NCT05917626 is sponsored by University of Malaga. The principal investigator is Rocio de la Vega, PhD at University of Malaga. The trial plans to enroll 195 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology